脂肪组织干细胞 (ASC) 和ASC衍生的细胞外膀可以防止实验性腹膜纤维化发展
Priscila Q Gouveia1, Camilla Fanelli1, Felipe M Ornellas1
1Laboratory of Cellular, Genetic, and Molecular Nephrology, Renal Division, Medical School, University of São Paulo, São Paulo 01246-903, Brazil.
Cells
|March 26, 2025
概括
脂肪组织衍生干细胞 (ASC) 和细胞外囊泡 (EV) 在治疗腹膜纤维化 (PF) 中表现有前途. 这两种疗法都减少了纤维化标志物和炎症,而EVs提供了优越的腹膜功能和超过能力的保护.
科学领域:
- 再生医学是一种再生医学.
- 细胞疗法细胞疗法
- 生物材料科学 生物材料科学
背景情况:
- 腹纤维化 (PF) 是腹透析的严重并发症,可能导致腹膜衰竭.
- 介酶体 stromal 细胞 (MSCs) 通过副膜机制为再生应用提供治疗潜力.
- 保护腹膜 (PM) 对于接受腹透析的患者至关重要.
研究的目的:
- 研究脂肪组织衍生干细胞 (ASC) 和细胞外囊泡 (EV) 在减轻腹膜纤维化 (PF) 的疗效.
- 评估ASCs和EVs对腹膜结构,纤维化标志物,炎症和鼠标模型中的功能的影响.
主要方法:
- 通过使用赫西丁葡萄糖酸盐来诱导腹膜纤维化 (PF) 的小鼠模型.
- 动物接受ASC或EV治疗,以评估它们的治疗效果.
- 分析了纤维化,炎症,基因表达 (Smad3,Smad7) 和腹膜功能 (超过能力,葡萄糖运输,新血管生成) 的关键标志物.
主要成果:
- 治疗ASC和EV显著防止了PM的加厚,并减少了肌纤维细胞,纤维素,原III,TGF-β和FSP-1.
- 这两种治疗都表现出强大的抗炎作用和调节Smad3/Smad7基因表达.
- 虽然VEGF表达减少了,但腹功能仍然有效,EVs显示出超过能力的卓越增强.
结论:
- 在实验模型中,ASC和EV有效地阻碍了PF的进展,并产生抗炎作用.
- EV治疗证明了腹膜功能的优越保护和增强的超过能力.
- ASCs和EVs代表了有希望的新型治疗策略,用于预防腹膜透析相关的PF.
更多相关视频
06:50Isolation of Adipogenic and Fibro-Inflammatory Stromal Cell Subpopulations from Murine Intra-Abdominal Adipose Depots
Published on: August 16, 2020
2.5K
10:50Author Spotlight: Isolation and Identification of Mesenchymal Stem Cells Derived from Adipose Tissue of Sprague Dawley Rats
Published on: April 7, 2023
3.0K
相关概念视频
01:19Mesenchymal Stem Cells
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...